FORM 2 - Corporate Substantial Shareholder Notice
 
Form Serial Number: CS20201022E00421 
1. Date of relevant event: 09/10/2020
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01952
4. Name of listed corporation: Everest Medicines Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 283,690,389
7. Name of substantial shareholder: VISTRA TRUST (SINGAPORE) PTE. LIMITED 
8. Registered office: 9 Raffles Place #26-01 Republic Plaza Singapore 048619
9. Principal place of business in Hong Kong: NA 
15. Exchange on which listed:
16. Name of listed parent and exchange on which parent is listed:  
17. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
2501Other (you must describe the capacity in the Supplementary Information box)
131,872,215
Short position 
 
 
 
           
18. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
   
19. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position131,872,21546.48
20. Capacity in which interests disclosed in Box 19 are held:
Capacity codeNumber of shares
2301Trustee
Long position122,340,215
2501Other (you must describe the capacity in the Supplementary Information box)
Long position9,532,000

21. Further information in respect of derivative interests:
Derivatives codeNumber of shares
  
22. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Nova Aqua LimitedBritish Virgin IslandsVistra Trust (Singapore) Pte. Limited100.00N
Long position131,872,215
TF Capital II, LtdCayman IslandsNova Aqua Limited47.83N
Long position50,000,000
C-Bridge Capital GP, Ltd.Cayman IslandsTF Capital II, Ltd38.34N
Long position50,000,000
C-Bridge Healthcare Fund GP II, L.P.Cayman IslandsC-Bridge Capital GP, Ltd.100.00N
Long position50,000,000
C-Bridge Healthcare Fund II, L.P.Cayman IslandsC-Bridge Healthcare Fund GP II, L.P.100.00N
Long position50,000,000
C-Bridge Investment Everest Limited3rd Floor, J&C Building, P.O. Box 933, Road Town, Tortola, VG1110, British Virgin IslandsC-Bridge Healthcare Fund II, L.P.100.00Y
Long position50,000,000
TF Capital IV, LtdCayman IslandsNova Aqua Limited100.00N
Long position53,639,823
C-Bridge Capital GP IV, Ltd.Maples Corporate Services Limited, P. O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsTF Capital IV, Ltd71.05N
Long position53,639,823
C-Bridge Healthcare Fund GP IV, L.P.Cayman IslandsC-Bridge Capital GP IV, Ltd.100.00N
Long position53,639,823
C-Bridge Healthcare Fund IV, L.P.Cayman IslandsC-Bridge Healthcare Fund GP IV, L.P.100.00N
Long position53,639,823
C-Bridge IV Investment Two LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.97.09Y
Long position38,362,045
C-Bridge IV Investment Nine LimitedBritish Virgin IslandsC-Bridge Healthcare Fund IV, L.P.100.00Y
Long position15,277,778
C-Bridge Value Creation LimitedGrand Pavilion Commercial Centre, Suite 24, 802 West Bay Road, P.O. Box 10281, Grand Cayman KY1-1003, Cayman IslandsNova Aqua Limited100.00N
Long position24,005,392
Everest Management Holding Co., LtdCayman IslandsC-Bridge Value Creation Limited78.32Y
Long position24,005,392
C-Bridge IV Investment Sixteen LimitedBritish Virgin IslandsNova Aqua Limited100.00Y
Long position4,227,000

23. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
24. Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
(Private trust)Addresses of individuals are not displayed.
5101Trustee of a trust
Long position131,872,215
25. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:
NamesAddressRelationship CodePercentage (%)
  
 
27. Supplementary information: For box 20, the long position of 9,532,000 shares represents the shares lent to Goldman Sachs International pursuant to a stock borrowing agreement, of which C-Bridge Investment Everest Limited is the lender, entered into prior to 09/10/2020 in connection with the initial public offering of shares of the listed corporation.
28. Log/Serial Number of the previous form:
29. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 2: 22/10/2020
(dd/mm/yyyy)